D. E. Shaw & Co., Inc. Baxter International Inc Transaction History

D. E. Shaw & Co., Inc.

$98.6 Billion
Q2 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Baxter International Inc stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 140,000 shares of BAX stock, worth $4.85 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

140,000

Holding current value

$4.85 Million

% of portfolio

0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$32.87 - $43.55 $3.3 Million - $4.37 Million	100,307 New	100,307 $3.36 Million
Q4 2023 Feb 14, 2024	SELL	$31.71 - $38.95 $18.5 Million - $22.8 Million	-584,377 Reduced 76.22%	182,351 $7.05 Million
Q3 2023 Nov 14, 2023	SELL	$37.32 - $49.29 $39 Million - $51.5 Million	-1,045,842 Reduced 57.7%	766,728 $28.9 Million
Q2 2023 Aug 14, 2023	SELL	$39.98 - $47.68 $47.7 Million - $56.9 Million	-1,193,668 Reduced 39.71%	1,812,570 $82.6 Million
Q1 2023 May 15, 2023	BUY	$37.58 - $52.57 $70.9 Million - $99.2 Million	1,886,914 Added 168.58%	3,006,238 $122 Million
Q4 2022 Feb 14, 2023	BUY	$49.7 - $57.71 $44.9 Million - $52.1 Million	903,291 Added 418.13%	1,119,324 $57.1 Million
Q3 2022 Nov 14, 2022	SELL	$53.86 - $66.8 $2.21 Million - $2.74 Million	-41,065 Reduced 15.97%	216,033 $11.6 Million
Q2 2022 Aug 15, 2022	SELL	$63.83 - $80.0 $33.6 Million - $42.1 Million	-526,744 Reduced 67.2%	257,098 $16.5 Million
Q1 2022 May 16, 2022	SELL	$76.85 - $89.45 $61.2 Million - $71.3 Million	-796,986 Reduced 50.42%	783,842 $60.8 Million
Q4 2021 Feb 14, 2022	SELL	$74.57 - $87.19 $58.9 Million - $68.9 Million	-790,483 Reduced 33.34%	1,580,828 $136 Million
Q3 2021 Nov 15, 2021	BUY	$73.77 - $83.61 $10.7 Million - $12.1 Million	144,980 Added 6.51%	2,371,311 $191 Million
Q2 2021 Aug 16, 2021	SELL	$80.5 - $88.01 $63.4 Million - $69.3 Million	-787,888 Reduced 26.14%	2,226,331 $179 Million
Q1 2021 May 17, 2021	SELL	$76.38 - $86.03 $74.4 Million - $83.8 Million	-974,013 Reduced 24.42%	3,014,219 $254 Million
Q4 2020 Feb 16, 2021	BUY	$75.39 - $82.36 $94.8 Million - $104 Million	1,257,502 Added 46.05%	3,988,232 $320 Million
Q3 2020 Nov 16, 2020	BUY	$78.33 - $90.73 $123 Million - $142 Million	1,570,024 Added 135.26%	2,730,730 $220 Million
Q2 2020 Aug 14, 2020	BUY	$78.66 - $94.14 $76.4 Million - $91.4 Million	970,967 Added 511.74%	1,160,706 $99.9 Million
Q1 2020 May 15, 2020	BUY	$71.57 - $93.3 $4.71 Million - $6.13 Million	65,752 Added 53.03%	189,739 $15.4 Million
Q4 2019 Feb 14, 2020	BUY	$76.7 - $88.45 $8.38 Million - $9.66 Million	109,225 Added 739.91%	123,987 $10.4 Million
Q3 2019 Nov 14, 2019	SELL	$81.4 - $89.78 $1.32 Million - $1.46 Million	-16,275 Reduced 52.44%	14,762 $1.29 Million
Q2 2019 Aug 14, 2019	SELL	$73.44 - $82.41 $12.8 Million - $14.3 Million	-174,042 Reduced 84.87%	31,037 $2.54 Million
Q1 2019 May 15, 2019	SELL	$64.48 - $81.31 $8.57 Million - $10.8 Million	-132,950 Reduced 39.33%	205,079 $16.7 Million
Q4 2018 Feb 14, 2019	SELL	$61.45 - $77.8 $7.64 Million - $9.67 Million	-124,308 Reduced 26.89%	338,029 $22.2 Million
Q3 2018 Nov 14, 2018	SELL	$70.71 - $77.75 $1.55 Million - $1.71 Million	-21,982 Reduced 4.54%	462,337 $35.6 Million
Q2 2018 Aug 14, 2018	SELL	$63.43 - $75.41 $37.5 Million - $44.6 Million	-591,086 Reduced 54.96%	484,319 $35.8 Million
Q1 2018 May 15, 2018	BUY	$62.56 - $72.26 $35.4 Million - $40.9 Million	565,966 Added 111.1%	1,075,405 $69.9 Million
Q4 2017 Feb 14, 2018	BUY	$61.45 - $66.05 $13.2 Million - $14.2 Million	215,508 Added 73.32%	509,439 $32.9 Million
Q3 2017 Nov 14, 2017	BUY	$59.5 - $64.61 $17.5 Million - $19 Million	293,931	293,931 $18.4 Million

Others Institutions Holding BAX

# of Institutions

998

Shares Held

450M

Call Options Held

1.97M

Put Options Held

3.04M

View Full List

About BAXTER INTERNATIONAL INC

Ticker BAX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 504,120,992
Market Cap $17.5B
Description
Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...

More about BAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account